177 related articles for article (PubMed ID: 1577745)
1. Ehlers Danlos syndrome type VIIB. Incomplete cleavage of abnormal type I procollagen by N-proteinase in vitro results in the formation of copolymers of collagen and partially cleaved pNcollagen that are near circular in cross-section.
Watson RB; Wallis GA; Holmes DF; Viljoen D; Byers PH; Kadler KE
J Biol Chem; 1992 May; 267(13):9093-100. PubMed ID: 1577745
[TBL] [Abstract][Full Text] [Related]
2. Ehlers-Danlos syndrome type VIIB. Morphology of type I collagen fibrils formed in vivo and in vitro is determined by the conformation of the retained N-propeptide.
Holmes DF; Watson RB; Steinmann B; Kadler KE
J Biol Chem; 1993 Jul; 268(21):15758-65. PubMed ID: 8340401
[TBL] [Abstract][Full Text] [Related]
3. Surface located procollagen N-propeptides on dermatosparactic collagen fibrils are not cleaved by procollagen N-proteinase and do not inhibit binding of decorin to the fibril surface.
Watson RB; Holmes DF; Graham HK; Nusgens BV; Kadler KE
J Mol Biol; 1998 Apr; 278(1):195-204. PubMed ID: 9571043
[TBL] [Abstract][Full Text] [Related]
4. A base substitution at the splice acceptor site of intron 5 of the COL1A2 gene activates a cryptic splice site within exon 6 and generates abnormal type I procollagen in a patient with Ehlers-Danlos syndrome type VII.
Chiodo AA; Hockey A; Cole WG
J Biol Chem; 1992 Mar; 267(9):6361-9. PubMed ID: 1556139
[TBL] [Abstract][Full Text] [Related]
5. Formation of collagen fibrils by enzymic cleavage of precursors of type I collagen in vitro.
Miyahara M; Hayashi K; Berger J; Tanzawa K; Njieha FK; Trelstad RL; Prockop DJ
J Biol Chem; 1984 Aug; 259(15):9891-8. PubMed ID: 6430905
[TBL] [Abstract][Full Text] [Related]
6. Further evidence that the failure to cleave the aminopropeptide of type I procollagen is the cause of Ehlers-Danlos syndrome type VII.
Ho KK; Kong RY; Kuffner T; Hsu LH; Ma L; Cheah KS
Hum Mutat; 1994; 3(4):358-64. PubMed ID: 8081389
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro noncovalent association of excised alpha 1 (I) amino-terminal propeptides with mutant pN alpha 2(I) collagen chains in native mutant collagen in a case of Ehlers-Danlos syndrome, type VII.
Wirtz MK; Keene DR; Hori H; Glanville RW; Steinmann B; Rao VH; Hollister DW
J Biol Chem; 1990 Apr; 265(11):6312-7. PubMed ID: 2318855
[TBL] [Abstract][Full Text] [Related]
8. A base substitution at a splice site in the COL3A1 gene causes exon skipping and generates abnormal type III procollagen in a patient with Ehlers-Danlos syndrome type IV.
Cole WG; Chiodo AA; Lamande SR; Janeczko R; Ramirez F; Dahl HH; Chan D; Bateman JF
J Biol Chem; 1990 Oct; 265(28):17070-7. PubMed ID: 2145268
[TBL] [Abstract][Full Text] [Related]
9. The clinical features of Ehlers-Danlos syndrome type VIIB resulting from a base substitution at the splice acceptor site of intron 5 of the COL1A2 gene.
Carr AJ; Chiodo AA; Hilton JM; Chow CW; Hockey A; Cole WG
J Med Genet; 1994 Apr; 31(4):306-11. PubMed ID: 8071956
[TBL] [Abstract][Full Text] [Related]
10. A mutation in the pro alpha 2(I) gene (COL1A2) for type I procollagen in Ehlers-Danlos syndrome type VII: evidence suggesting that skipping of exon 6 in RNA splicing may be a common cause of the phenotype.
Vasan NS; Kuivaniemi H; Vogel BE; Minor RR; Wootton JA; Tromp G; Weksberg R; Prockop DJ
Am J Hum Genet; 1991 Feb; 48(2):305-17. PubMed ID: 1990839
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a structural mutation of procollagen type I in a patient with the Ehlers-Danlos syndrome type VII.
Steinmann B; Tuderman L; Peltonen L; Martin GR; McKusick VA; Prockop DJ
J Biol Chem; 1980 Sep; 255(18):8887-93. PubMed ID: 6773953
[TBL] [Abstract][Full Text] [Related]
12. Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen.
Byers PH; Duvic M; Atkinson M; Robinow M; Smith LT; Krane SM; Greally MT; Ludman M; Matalon R; Pauker S; Quanbeck D; Schwarze U
Am J Med Genet; 1997 Oct; 72(1):94-105. PubMed ID: 9295084
[TBL] [Abstract][Full Text] [Related]
13. Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen.
Smith LT; Wertelecki W; Milstone LM; Petty EM; Seashore MR; Braverman IM; Jenkins TG; Byers PH
Am J Hum Genet; 1992 Aug; 51(2):235-44. PubMed ID: 1642226
[TBL] [Abstract][Full Text] [Related]
14. Identification of a mutation that causes exon skipping during collagen pre-mRNA splicing in an Ehlers-Danlos syndrome variant.
Weil D; Bernard M; Combates N; Wirtz MK; Hollister DW; Steinmann B; Ramirez F
J Biol Chem; 1988 Jun; 263(18):8561-4. PubMed ID: 2454224
[TBL] [Abstract][Full Text] [Related]
15. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
Schwarze U; Schievink WI; Petty E; Jaff MR; Babovic-Vuksanovic D; Cherry KJ; Pepin M; Byers PH
Am J Hum Genet; 2001 Nov; 69(5):989-1001. PubMed ID: 11577371
[TBL] [Abstract][Full Text] [Related]
16. Mutations near amino end of alpha1(I) collagen cause combined osteogenesis imperfecta/Ehlers-Danlos syndrome by interference with N-propeptide processing.
Cabral WA; Makareeva E; Colige A; Letocha AD; Ty JM; Yeowell HN; Pals G; Leikin S; Marini JC
J Biol Chem; 2005 May; 280(19):19259-69. PubMed ID: 15728585
[TBL] [Abstract][Full Text] [Related]
17. Abnormal type III collagen produced by an exon-17-skipping mutation of the COL3A1 gene in Ehlers-Danlos syndrome type IV is not incorporated into the extracellular matrix.
Chiodo AA; Sillence DO; Cole WG; Bateman JF
Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):939-43. PubMed ID: 7487954
[TBL] [Abstract][Full Text] [Related]
18. Formation of collagen fibrils in vitro by cleavage of procollagen with procollagen proteinases.
Miyahara M; Njieha FK; Prockop DJ
J Biol Chem; 1982 Jul; 257(14):8442-8. PubMed ID: 6806297
[TBL] [Abstract][Full Text] [Related]
19. A heterozygous collagen defect in a variant of the Ehlers-Danlos syndrome type VII. Evidence for a deleted amino-telopeptide domain in the pro-alpha 2(I) chain.
Eyre DR; Shapiro FD; Aldridge JF
J Biol Chem; 1985 Sep; 260(20):11322-9. PubMed ID: 2993307
[TBL] [Abstract][Full Text] [Related]
20. Polymerization of pNcollagen I and copolymerization of pNcollagen I with collagen I. A kinetic, thermodynamic, and morphologic study.
Romanic AM; Adachi E; Hojima Y; Engel J; Prockop DJ
J Biol Chem; 1992 Nov; 267(31):22265-71. PubMed ID: 1331049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
